Complex 3D Organoid/Tissue Models and Patient-Derived Disease Models

Complex 3D Organoid/Tissue Models and Patient-Derived Disease Models

These services allow for the design and generation of complex 3D organ/tissue models (e.g., organoids, multi-organ-on-chip systems) as well as patient-derived cell-based disease models (e.g., fibroblasts, iPSCs, neural precursor cells, smNPCs). Enabling technologies such as vector design, advanced imaging, hydrogel fabrication, microfluidics, and organ-on-chip manufacturing are also covered. These models support non-clinical testing of advanced therapies (e.g., CRISPR editing, CAR-based therapies, nanotechnology approaches) as well as functional screening, drug efficacy profiling, and personalised pharmacological modulation.